Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-2007 | 07-2006 | 07-2005 | 07-2004 | 07-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,572 | 12,909 | 14,280 | 4,310 | 1,504 |
| Marketable Securities | 1,630 | 327 | N/A | N/A | N/A |
| Receivables | 740 | 3,832 | 4,086 | 830 | 957 |
| Inventories | 45 | N/A | N/A | N/A | N/A |
| TOTAL | $9,364 | $17,485 | $18,638 | $5,349 | $2,737 |
| Non-Current Assets | |||||
| PPE Net | 304 | 149 | 35 | 19 | 30 |
| Investments And Advances | 0 | 499 | 558 | 0 | 43 |
| Intangibles | 0 | 20 | 39 | 52 | 143 |
| Other Non-Current Assets | 44 | 265 | 171 | 1,260 | 0 |
| TOTAL | $348 | $932 | $803 | $1,332 | $216 |
| Total Assets | $9,713 | $18,417 | $19,441 | $6,681 | $2,953 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 728 | 585 | 643 | 163 | 502 |
| Accrued Expenses | 1,324 | 3,378 | 4,690 | 1,579 | 1,281 |
| TOTAL | $2,051 | $3,963 | $5,333 | $1,742 | $1,783 |
| Non-Current Liabilities | |||||
| TOTAL | $63 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,114 | $3,963 | $5,333 | $1,742 | $1,783 |
| Shareholders' Equity | |||||
| Common Shares | 81 | 80 | 73 | 64 | 62 |
| Retained earnings | -28,315 | -19,421 | -17,044 | -22,746 | -25,701 |
| Other shareholders' equity | 509 | -295 | -267 | 0 | 0 |
| TOTAL | $7,599 | $14,454 | $14,108 | $4,939 | $1,169 |
| Total Liabilities And Equity | $9,713 | $18,417 | $19,441 | $6,681 | $2,953 |